Meget sjældent kan patienter, som tager Temodal eller lignende medicin, have en lille risiko for at udvikle en sekundær kræftform, inklusiv leukæmi.
In very rare cases, patients taking Temodal and medicines like it may have a small risk of developing secondary cancers, including leukaemia.